{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T03:58:44Z","timestamp":1768967924535,"version":"3.49.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.lpm.2017.10.014","type":"journal-article","created":{"date-parts":[[2017,11,19]],"date-time":"2017-11-19T20:30:26Z","timestamp":1511123426000},"page":"e312-e328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"P2","title":["Iatrogenic iron overload and its potential consequences in patients on hemodialysis"],"prefix":"10.1016","volume":"46","author":[{"given":"Guy","family":"Rostoker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nosratola D.","family":"Vaziri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lpm.2017.10.014_bib0510","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1681\/ASN.2006080856","article-title":"Clinical aspects of iron use in the anemia of kidney disease","volume":"18","author":"H\u00f6rl","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl. 2","key":"10.1016\/j.lpm.2017.10.014_bib0515","first-page":"ii1","article-title":"Revised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure","volume":"19","author":"Locatelli","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.lpm.2017.10.014_bib0520","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s40265-016-0569-0","article-title":"Iatrogenic iron overload in dialysis patients at the beginning of the 21st century","volume":"76","author":"Rostoker","year":"2016","journal-title":"Drugs"},{"issue":"5 Suppl. 3","key":"10.1016\/j.lpm.2017.10.014_bib0525","first-page":"Sl6","article-title":"Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults","volume":"47","author":"KDOQI National Kidney Foundation","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.lpm.2017.10.014_bib0530","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.2215\/CJN.01390406","article-title":"The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease?","volume":"1","author":"Kalantar-Zadeh","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8273","key":"10.1016\/j.lpm.2017.10.014_bib0535","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0140-6736(82)92204-8","article-title":"Failure of serum ferritin levels to predict bone marrow iron content after intravenous iron dextran therapy","volume":"1","author":"Ali","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2017.10.014_bib0540","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69035.x","article-title":"Iron overload in renal failure patients: change since the introduction of erythropoietin therapy","volume":"69","author":"Eschbach","year":"1999","journal-title":"Kidney Int Suppl"},{"issue":"10","key":"10.1016\/j.lpm.2017.10.014_bib0545","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.amjmed.2012.01.015","article-title":"Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study","volume":"125","author":"Rostoker","year":"2012","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.lpm.2017.10.014_bib0550","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.amjmed.2012.02.009","article-title":"Epidemic of iron overload in dialysis population caused by intravenous iron products: a plea for moderation","volume":"125","author":"Vaziri","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2017.10.014_bib0555","series-title":"Handbook of iron overload disorders","author":"Barton","year":"2010"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.014_bib0560","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1523-1755.2004.00480.x","article-title":"Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients","volume":"65","author":"Canavese","year":"2004","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.lpm.2017.10.014_bib0565","doi-asserted-by":"crossref","first-page":"e50295","DOI":"10.1371\/journal.pone.0050295","article-title":"Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients","volume":"7","author":"Kuo","year":"2012","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.lpm.2017.10.014_bib0570","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/ki.2014.114","article-title":"Association between hemoglobin variability, serum ferritin levels, and adverse events\/mortality in maintenance hemodialysis patients","volume":"86","author":"Kuragano","year":"2014","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.014_bib0575","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ki.2014.275","article-title":"Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality","volume":"87","author":"Bailie","year":"2015","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.014_bib0580","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/ndt\/gfu104","article-title":"Iron dosing in kidney disease: inconsistency of evidence and clinical practice","volume":"30","author":"Gaweda","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.014_bib0585","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/ndt\/gft269","article-title":"Iron toxicity: relevance for dialysis patients","volume":"29","author":"Fishbane","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.lpm.2017.10.014_bib0590","first-page":"279","article-title":"KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group","year":"2012","journal-title":"Kidney Inter Suppl"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.014_bib0595","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/ndt\/gfn653","article-title":"Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP)","volume":"24","author":"Locatelli","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.lpm.2017.10.014_bib0600","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.kint.2015.10.002","article-title":"Iron management in chronic kidney disease: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"89","author":"Macdougall","year":"2016","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.lpm.2017.10.014_bib0605","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1681\/ASN.2014090922","article-title":"Considerations and challenges in defining optimal iron utilization in hemodialysis","volume":"26","author":"Charytan","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.014_bib0610","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1525-139X.2011.00938.x","article-title":"Limiting iron supplementation for anemia in dialysis patients\u00a0\u2013\u00a0the Basis for Japan's conservative guidelines","volume":"24","author":"Yamamoto","year":"2011","journal-title":"Semin Dial"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.014_bib0615","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000074931","article-title":"Iron requirements in hemodialysis","volume":"22","author":"Sargent","year":"2004","journal-title":"Blood Purif"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.014_bib0620","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000046213","article-title":"Comparison of blood loss with different high-flux and high-efficiency hemodialysis membranes","volume":"21","author":"Otti","year":"2001","journal-title":"Am J Nephrol"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.014_bib0625","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/039139880602900306","article-title":"Residual blood loss in single use dialyzers: effect of different membranes and flux","volume":"29","author":"Kalocheretis","year":"2006","journal-title":"Int J Artif Organs"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.014_bib0630","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000444335","article-title":"Annual iron loss associated with hemodialysis","volume":"43","author":"Tsukamoto","year":"2016","journal-title":"Am J Nephrol"},{"issue":"7","key":"10.1016\/j.lpm.2017.10.014_bib0635","first-page":"531","article-title":"Use of intravenous iron supplementation in chronic kidney disease: interests, limits, and recommendations for a better practice","volume":"11","author":"Rottembourg","year":"2015","journal-title":"Neprol Therap"},{"issue":"4","key":"10.1016\/j.lpm.2017.10.014_bib0640","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0272-6386(82)80059-0","article-title":"Gastrointestinal blood loss in patients with chronic renal failure","volume":"1","author":"Rosenblatt","year":"1982","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.014_bib0645","doi-asserted-by":"crossref","first-page":"c38","DOI":"10.1159\/000228074","article-title":"Increased iron requirement in hemodialysis patients on antiplatelet agents or warfarin","volume":"113","author":"Flint","year":"2009","journal-title":"Nephron Clin Pract"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.014_bib0650","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/ajkd.2000.8275","article-title":"Antiplatelet therapy alters iron requirements in hemodialysis patients","volume":"36","author":"Goicoechea","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.014_bib0655","first-page":"296","article-title":"Safety of intravenous iron formulations: facts and folklore","volume":"12","author":"Auerbach","year":"2014","journal-title":"Blood Transfus"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.014_bib0660","first-page":"9","article-title":"Use of intravenous iron supplementation in chronic kidney disease: an update","volume":"7","author":"Macdougall","year":"2013","journal-title":"Iran J Kidney Dis"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.014_bib0665","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0272-6386(95)90151-5","article-title":"Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation","volume":"26","author":"Fishbane","year":"1995","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.014_bib0670","first-page":"CD007857","article-title":"Parenteral versus oral iron therapy for adults and children with chronic kidney disease","volume":"18","author":"Albaramki","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2017.10.014_bib0675","unstructured":"European Medicines Agency. http:\/\/www.emea.europa.eu\/."},{"key":"10.1016\/j.lpm.2017.10.014_bib0680","series-title":"Reflection paper on the data requirements for intravenous iron-based nano-colloidal products developed with reference to an innovator medicinal product. EMA\/CHMP\/SWP\/620008\/2012","author":"Committee for Medicinal Products for Human Use (CHMP)","year":"2015"},{"issue":"9","key":"10.1016\/j.lpm.2017.10.014_bib0685","first-page":"846","article-title":"Monitoring of iron requirements in renal patients on erythropoietin","volume":"8","author":"Anastassiades","year":"1993","journal-title":"Nephrol Dial Transplant"},{"issue":"1 Suppl. 2","key":"10.1016\/j.lpm.2017.10.014_bib0690","first-page":"21","article-title":"Iron deficiency in patients with dialysis-associated anemia during erythropoietin replacement therapy: strategies for assessment and management","volume":"9","author":"Van Wyck","year":"1989","journal-title":"Semin Nephrol"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.014_bib0695","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0272-6386(99)70127-7","article-title":"Iron replacement in rHuEPO-treated dialysis patients: DOQI and Beyond","volume":"34","author":"Mittman","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.lpm.2017.10.014_bib0700","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.amjmed.2012.03.011","article-title":"Changing patterns of anemia management in US hemodialysis patients","volume":"125","author":"Freburger","year":"2012","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.014_bib0705","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1053\/j.ajkd.2012.04.001","article-title":"The DOPPS practice monitor for US dialysis care: trends through August 2011","volume":"60","author":"Pisoni","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.lpm.2017.10.014_bib0710","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1093\/ndt\/gft062","article-title":"Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"28","author":"Bailie","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1016\/j.lpm.2017.10.014_bib0715","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.2215\/CJN.02600315","article-title":"Understanding the recent increase in ferritin levels United States dialysis patients: Potential impact of changes in intravenous iron and erythropoiesis-stimulating agent dosing","volume":"10","author":"Karaboyas","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.lpm.2017.10.014_bib0720","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/jama.1980.03310040025019","article-title":"Hemosiderosis in hemodialysis patients. An autopsy study of 50 cases","volume":"244","author":"Ali","year":"1980","journal-title":"JAMA"},{"issue":"4\u20136","key":"10.1016\/j.lpm.2017.10.014_bib0725","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000181469","article-title":"Hemosiderosis secondary to chronic parenteral iron therapy in maintenance hemodialysis patients","volume":"22","author":"Pitts","year":"1978","journal-title":"Nephron"},{"issue":"191","key":"10.1016\/j.lpm.2017.10.014_bib0730","first-page":"369","article-title":"Iron metabolism in haemodialysis patients. A study of the management of iron therapy and overload","volume":"48","author":"Gokal","year":"1979","journal-title":"Q J Med"},{"issue":"1\u20133","key":"10.1016\/j.lpm.2017.10.014_bib0735","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000169400","article-title":"Detoxification in hemosiderosis","volume":"3","author":"Simon","year":"1985","journal-title":"Blood Purif"},{"issue":"7","key":"10.1016\/j.lpm.2017.10.014_bib0740","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/039139889101400704","article-title":"Combined recombinant human erythropoietin-blood letting strategy for treating anemia and iron overload in hemodialysis patients","volume":"14","author":"Agroyannis","year":"1991","journal-title":"Int J Artif Organs"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.014_bib0745","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ki.1990.69","article-title":"Efficacy of hepatic computed tomography to detect iron overload in chronic hemodialysis","volume":"37","author":"Cecchin","year":"1990","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.lpm.2017.10.014_bib0750","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM200008033430503","article-title":"Hepatic iron concentration and total body iron stores in thalassemia major","volume":"343","author":"Angelucci","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.lpm.2017.10.014_bib0755","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.blre.2008.03.001","article-title":"Current approach to hemochromatosis","volume":"22","author":"Brissot","year":"2008","journal-title":"Blood Rev"},{"key":"10.1016\/j.lpm.2017.10.014_bib0760","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/asheducation-2009.1.215","article-title":"Non-invasive assessment of tissue iron overload","volume":"1","author":"Fischer","year":"2009","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.014_bib0765","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ejrad.2006.11.012","article-title":"Iron overload in the liver diagnostic and quantification","volume":"61","author":"Al\u00fastiza","year":"2007","journal-title":"Eur J Radiol"},{"issue":"9406","key":"10.1016\/j.lpm.2017.10.014_bib0770","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0140-6736(04)15436-6","article-title":"Non-invasive assessment of hepatic iron stores by MRI","volume":"363","author":"Gandon","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.014_bib0775","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood-2004-01-0177","article-title":"Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance","volume":"105","author":"St Pierre","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.lpm.2017.10.014_bib0780","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2004-10-3982","article-title":"MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients","volume":"106","author":"Wood","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2017.10.014_bib0785","doi-asserted-by":"crossref","first-page":"e000226","DOI":"10.1016\/j.heliyon.2016.e00226","article-title":"Signal-intensity-ratio MRI accurately estimates hepatic iron load in hemodialysis patients","volume":"3","author":"Rostoker","year":"2017","journal-title":"Heliyon"},{"issue":"6","key":"10.1016\/j.lpm.2017.10.014_bib0790","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/RCT.0000000000000146","article-title":"Magnetic resonance imaging repercussions of intravenous iron products used for iron-deficiency anemia and dialysis-associated anemia","volume":"38","author":"Rostoker","year":"2014","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.lpm.2017.10.014_bib0795","unstructured":"European Medicines Agency. Rienso: EPAR-Product information. 2015. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002215\/WC500129749.pdf."},{"issue":"1","key":"10.1016\/j.lpm.2017.10.014_bib0800","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2215\/CJN.04190510","article-title":"Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease","volume":"6","author":"Ferrari","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.014_bib0805","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-0609.2012.01783.x","article-title":"Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron","volume":"89","author":"Ghoti","year":"2012","journal-title":"Eur J Haematol"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.014_bib0810","first-page":"68","article-title":"Liver and cardiac iron deposition in patients on maintenance hemodialysis by magnetic resonance imaging T2","volume":"10","author":"Tolouian","year":"2016","journal-title":"Iran J Kidney Dis"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.014_bib0815","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/nep.12735","article-title":"Characterization of hepatic and cardiac iron deposition during standard treatment of anaemia in haemodialysis","volume":"22","author":"Holman","year":"2017","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.lpm.2017.10.014_bib0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.ekir.2017.07.005","article-title":"Hepatic iron load at MRI is normal in most peritoneal dialysis patients","author":"Issad","year":"2017","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.014_bib0825","first-page":"9","article-title":"Liver iron content by MRI at the start of hemodialysis","volume":"1","author":"Carrilho","year":"2017","journal-title":"Adv Kidney Dis Treat"},{"issue":"6","key":"10.1016\/j.lpm.2017.10.014_bib0830","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1097\/01.ASN.0000128009.69594.BE","article-title":"Administration of parenteral iron and mortality among hemodialysis patients","volume":"15","author":"Feldman","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.lpm.2017.10.014_bib0835","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.2215\/CJN.03370414","article-title":"Intravenous iron exposure and mortality in patients on hemodialysis","volume":"9","author":"Miskulin","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.lpm.2017.10.014_bib0840","doi-asserted-by":"crossref","first-page":"e78930","DOI":"10.1371\/journal.pone.0078930","article-title":"Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients","volume":"8","author":"Kshirsagar","year":"2013","journal-title":"Plos One"},{"issue":"10","key":"10.1016\/j.lpm.2017.10.014_bib0845","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1681\/ASN.2005040423","article-title":"Time-dependent associations between iron and mortality in hemodialysis patients","volume":"16","author":"Kalantar-Zadeh","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.lpm.2017.10.014_bib0850","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1681\/ASN.2012121164","article-title":"Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients","volume":"24","author":"Brookhart","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.lpm.2017.10.014_bib0855","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ki.2015.163","article-title":"A randomized trial of intravenous and oral iron in chronic kidney disease","volume":"88","author":"Agarwal","year":"2015","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.lpm.2017.10.014_bib0860","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1515\/cclm-2013-0769","article-title":"Hepcidin levels in chronic hemodialysis patients: a critical evaluation","volume":"52","author":"Valenti","year":"2014","journal-title":"Clin Chem Lab Med"},{"issue":"12","key":"10.1016\/j.lpm.2017.10.014_bib0865","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/ndt\/gfs488","article-title":"Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients","volume":"28","author":"Van der Weerd","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.lpm.2017.10.014_bib0870","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1046\/j.1523-1755.2002.00600.x","article-title":"The elephant in uremia: oxidant stress as an unifying concept of cardiovascular disease in uremia","volume":"62","author":"Himmelfarb","year":"2002","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.lpm.2017.10.014_bib0875","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1681\/ASN.2015010052","article-title":"The labile side of iron supplementation in CKD","volume":"26","author":"Slotki","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.lpm.2017.10.014_bib0880","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/S0735-1097(02)02611-6","article-title":"Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis","volume":"40","author":"Gaenzer","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.lpm.2017.10.014_bib0885","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000035250.66458.67","article-title":"Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease","volume":"106","author":"Dr\u00fceke","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.014_bib0890","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1536\/ihj.46.255","article-title":"Intravenous iron therapy as a possible risk factor for atherosclerosis in end-stage renal disease","volume":"46","author":"Reis","year":"2005","journal-title":"Int Heart J"},{"key":"10.1016\/j.lpm.2017.10.014_bib0895","series-title":"Chronic renal disease","first-page":"285","article-title":"Immune function in chronic kidney disease","author":"Pahl","year":"2015"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.014_bib0900","first-page":"64","article-title":"At pharmacologically relevant concentrations intravenous iron preparations cause pancreatic beta cell death","volume":"6","author":"Masuda","year":"2013","journal-title":"Am J Transl Res"},{"issue":"6","key":"10.1016\/j.lpm.2017.10.014_bib0905","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(13)70174-8","article-title":"Effects of iron overload on chronic metabolic diseases","volume":"2","author":"Fern\u00e1ndez-Real","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.lpm.2017.10.014_bib0910","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/ndt\/gft033","article-title":"Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement","volume":"28","author":"Locatelli","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.lpm.2017.10.014_bib0915","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1053\/j.ajkd.2012.10.027","article-title":"Understanding iron: promoting its safe use in patients with chronic kidney failure treated by hemodialysis","volume":"61","author":"Vaziri","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.014_bib0920","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.blre.2015.07.006","article-title":"Iron therapy in chronic kidney disease: recent changes, benefits and risks","volume":"30","author":"Ribeiro","year":"2016","journal-title":"Blood Rev"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.014_bib0925","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000440773","article-title":"How to supplement iron in patients with renal anemia","volume":"131","author":"Tanaka","year":"2015","journal-title":"Nephron"},{"issue":"10","key":"10.1016\/j.lpm.2017.10.014_bib0930","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.dld.2013.02.019","article-title":"Iron deficiency: from diagnosis to treatment","volume":"45","author":"Polin","year":"2013","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.014_bib0935","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/1871529X1303140129155609","article-title":"Iron supplementation therapy in end-stage renal disease patients on maintenance hemodialysis","volume":"13","author":"Shibata","year":"2013","journal-title":"Cardiovasc Haematol Disord Drug Targets"},{"issue":"12","key":"10.1016\/j.lpm.2017.10.014_bib0940","doi-asserted-by":"crossref","first-page":"e115096","DOI":"10.1371\/journal.pone.0115096","article-title":"Maximal standard dose of parenteral iron for hemodialysis patients: an MRI-based decision tree learning analysis","volume":"9","author":"Rostoker","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.lpm.2017.10.014_bib0945","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1159\/000370317","article-title":"Low levels of serum ferritin lead to adequate hemoglobin levels and good survival in hemodialysis patients","volume":"40","author":"Ogawa","year":"2014","journal-title":"Am J Nephrol"},{"issue":"4","key":"10.1016\/j.lpm.2017.10.014_bib0950","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1586\/17474086.2014.941349","article-title":"Anemia in chronic kidney disease patients: treatment recommendations and emerging therapies","volume":"7","author":"Del Vecchio","year":"2014","journal-title":"Expert Rev Hematol"},{"issue":"5","key":"10.1016\/j.lpm.2017.10.014_bib0955","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ki.2015.203","article-title":"Ferric pyrophosphate citrate administered via dialysate reduces erythropoiesis-stimulating agent use and maintains hemoglobin in hemodialysis patients","volume":"88","author":"Gupta","year":"2015","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.lpm.2017.10.014_bib0960","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1681\/ASN.2014080842","article-title":"Ferric citrate reduces intravenous iron and erythropoiesis-stimulating agent use in ESRD","volume":"26","author":"Umanath","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.lpm.2017.10.014_bib0965","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1681\/ASN.2015020135","article-title":"Is it too much of a good thing? A new era in phosphate binder therapy in ESRD","volume":"26","author":"Qunibi","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.lpm.2017.10.014_bib0970","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/ndt\/gfv268","article-title":"Novel iron-containing phosphate binders and anemia treatment in CKD: oral iron intake revisited","volume":"31","author":"Nakanishi","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.lpm.2017.10.014_bib0975","series-title":"Auryxia\u00ae: summary of the characteristics of the product","author":"FDA","year":"2014"},{"issue":"5","key":"10.1016\/j.lpm.2017.10.014_bib0980","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/ndt\/gfv095","article-title":"Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment","volume":"31","author":"Vaziri","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.lpm.2017.10.014_bib0985","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1093\/ndt\/gfr624","article-title":"Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation","volume":"27","author":"Vaziri","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.014_bib0990","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000353764","article-title":"Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction","volume":"38","author":"Vaziri","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.lpm.2017.10.014_bib0995","series-title":"EU Clinical Trials Register: Proactive IV irOn Therapy for HaemodiALysis patients (PIVOTAL)","author":"Macdougall","year":"2013"},{"issue":"suppl. 1","key":"10.1016\/j.lpm.2017.10.014_bib1000","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1111\/hdi.12557","article-title":"Impact of iatrogenic iron overload on the course of hepatitis C in dialysis population: a plea for caution","volume":"21","author":"Rostoker","year":"2017","journal-title":"Hemodialysis Int"},{"issue":"7","key":"10.1016\/j.lpm.2017.10.014_bib1005","doi-asserted-by":"crossref","first-page":"e0132006","DOI":"10.1371\/journal.pone.0132006","article-title":"Reassessment of iron biomarkers for prediction of dialysis iron overload: an MRI study","volume":"10","author":"Rostoker","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.lpm.2017.10.014_bib1010","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3324\/haematol.12413","article-title":"Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders","volume":"93","author":"Angelucci","year":"2008","journal-title":"Haematologica"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498217304670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498217304670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T05:47:48Z","timestamp":1570340868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498217304670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":101,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0755498217304670"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2017.10.014","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iatrogenic iron overload and its potential consequences in patients on hemodialysis","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2017.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}